266 related articles for article (PubMed ID: 11258606)
1. The severity of hyperdynamic circulation may predict the effects of direct hemoperfusion with the adsorbent column using polymyxin B-immobilized fiber in patients with gram-negative septic shock.
Uriu K; Osajima A; Kamochi M; Watanabe H; Aibara K; Kaizu K
Ther Apher; 2001 Feb; 5(1):25-30. PubMed ID: 11258606
[TBL] [Abstract][Full Text] [Related]
2. Endotoxin removal by direct hemoperfusion with an adsorbent column using polymyxin B-immobilized fiber ameliorates systemic circulatory disturbance in patients with septic shock.
Uriu K; Osajima A; Hiroshige K; Watanabe H; Aibara K; Inada Y; Segawa K; Anai H; Takagi I; Ito A; Kamochi M; Kaizu K
Am J Kidney Dis; 2002 May; 39(5):937-47. PubMed ID: 11979337
[TBL] [Abstract][Full Text] [Related]
3. Effect of direct hemoperfusion using polymyxin B immobilized fiber on inflammatory mediators in patients with severe sepsis and septic shock.
Kanesaka S; Sasaki J; Kuzume M; Narihara K; Takahashi Y
Int J Artif Organs; 2008 Oct; 31(10):891-7. PubMed ID: 19009507
[TBL] [Abstract][Full Text] [Related]
4. Clinical Effects of a Longer Duration of Polymyxin B-Immobilized Fiber Column Direct Hemoperfusion Therapy for Severe Sepsis and Septic Shock.
Yamashita C; Hara Y; Kuriyama N; Nakamura T; Nishida O
Ther Apher Dial; 2015 Aug; 19(4):316-23. PubMed ID: 26386218
[TBL] [Abstract][Full Text] [Related]
5. Early induction of direct hemoperfusion with a polymyxin-B immobilized column is associated with amelioration of hemodynamic derangement and mortality in patients with septic shock.
Chihara S; Masuda Y; Tatsumi H; Nakano K; Shimada T; Murohashi T; Yamakage M
J Artif Organs; 2017 Mar; 20(1):71-75. PubMed ID: 27469940
[TBL] [Abstract][Full Text] [Related]
6. Removal of 2-arachidonylglycerol by direct hemoperfusion therapy with polymyxin B immobilized fibers benefits patients with septic shock.
Kase Y; Obata T; Okamoto Y; Iwai K; Saito K; Yokoyama K; Takinami M; Tanifuji Y
Ther Apher Dial; 2008 Oct; 12(5):374-80. PubMed ID: 18937720
[TBL] [Abstract][Full Text] [Related]
7. Relationship between effect of polymyxin B-immobilized fiber and high-mobility group box-1 protein in septic shock patients.
Sakamoto Y; Mashiko K; Matsumoto H; Hara Y; Kutsukata N; Yamamoto Y
ASAIO J; 2007; 53(3):324-8. PubMed ID: 17515723
[TBL] [Abstract][Full Text] [Related]
8. Angiopoietin Balance in Septic Shock Patients With Acute Kidney Injury: Effects of Direct Hemoperfusion With Polymyxin B-Immobilized Fiber.
Ebihara I; Hirayama K; Nagai M; Shiina E; Koda M; Gunji M; Okubo Y; Sato C; Usui J; Yamagata K; Kobayashi M
Ther Apher Dial; 2016 Aug; 20(4):368-75. PubMed ID: 27523077
[TBL] [Abstract][Full Text] [Related]
9. Polymyxin B-immobilized fiber column hemoperfusion therapy for septic shock.
Mitaka C; Tomita M
Shock; 2011 Oct; 36(4):332-8. PubMed ID: 21654557
[TBL] [Abstract][Full Text] [Related]
10. Sphingosine-1-Phosphate (S1P) Is a Feasible Biomarker in Predicting the Efficacy of Polymyxin B-Immobilized Fiber Direct Hemoperfusion (PMX-DHP) in Patients with Septic Shock.
Inoue S; Sakamoto Y; Koami H; Yamada C K; Nagashima F; Miike T; Iwamura T; Obata T
J Nippon Med Sch; 2018; 85(1):39-46. PubMed ID: 29540645
[TBL] [Abstract][Full Text] [Related]
11. Urinary liver-type fatty acid-binding protein in septic shock: effect of polymyxin B-immobilized fiber hemoperfusion.
Nakamura T; Sugaya T; Koide H
Shock; 2009 May; 31(5):454-9. PubMed ID: 18838948
[TBL] [Abstract][Full Text] [Related]
12. Clinical responses and improvement of some laboratory parameters following polymyxin B-immobilized fiber treatment in septic shock.
Sakamoto Y; Mashiko K; Obata T; Matsumoto H; Hara Y; Kutsukata N; Yamamoto Y
ASAIO J; 2007; 53(5):646-50. PubMed ID: 17885340
[TBL] [Abstract][Full Text] [Related]
13. Clinical effects of direct hemoperfusion using a polymyxin-B immobilized column in solid organ transplanted patients with signs of severe sepsis and septic shock. A pilot study.
Ruberto F; Pugliese F; D'Alio A; Martelli S; Bruno K; Marcellino V; Summonti D; Celli P; Perrella S; Cappannoli A; Pietropaoli C; Tosi A; Diana B; Novelli G; Rossi M; Ginanni-Corradini S; Ferretti G; Berloco PB; Pietropaoli P
Int J Artif Organs; 2007 Oct; 30(10):915-22. PubMed ID: 17992653
[TBL] [Abstract][Full Text] [Related]
14. Clinical Effects of Polymyxin B Hemoperfusion in Patients With Septic Shock Caused by Urinary Tract Infection.
Suzuki Y; Kojika M; Sato H; Inoue Y; Endo S
Ther Apher Dial; 2019 Feb; 23(1):80-85. PubMed ID: 30209889
[TBL] [Abstract][Full Text] [Related]
15. pH after the first session of direct hemoperfusion with polymyxin B-immobilized fibers predicts mortality in patients with sepsis and septic shock.
Okubo A; Nakashima A; Doi S; Ueno T; Sasaki K; Esaki T; Masaki T
Clin Exp Nephrol; 2018 Oct; 22(5):1167-1173. PubMed ID: 29478200
[TBL] [Abstract][Full Text] [Related]
16. Lactate predicts the 28-day survival rate in patients with septic shock treated with the combination of PMX-DHP and rTM.
Yamato M; Asahina Y; Koizumi S; Shigeki T; Yajima A; Kimura Y; Iwatani H
Ther Apher Dial; 2020 Oct; 24(5):492-498. PubMed ID: 32524733
[TBL] [Abstract][Full Text] [Related]
17. Endotoxin adsorption therapy for septic shock using polymyxin B-immobilized fibers (PMX): evaluation by high-sensitivity endotoxin assay and measurement of the cytokine production capacity.
Kojika M; Sato N; Yaegashi Y; Suzuki Y; Suzuki K; Nakae H; Endo S
Ther Apher Dial; 2006 Feb; 10(1):12-8. PubMed ID: 16556131
[TBL] [Abstract][Full Text] [Related]
18. [Endotoxin eliminating therapy in patients with severe sepsis--direct hemoperfusion using polymyxin B immobilized fiber column].
Kodama M; Tani T; Maekawa K; Hirasawa H; Otsuka T; Takahashi Y; Kaneko M
Nihon Geka Gakkai Zasshi; 1995 May; 96(5):277-85. PubMed ID: 7596338
[TBL] [Abstract][Full Text] [Related]
19. [Polymyxin-B direct hemoperfusion (PMX-DHP) in gram negative sepsis].
Perego AF; Morabito S; Graziani G; Casella GP; Parodi O
G Ital Nefrol; 2006; 23 Suppl 36():S94-102. PubMed ID: 17068736
[TBL] [Abstract][Full Text] [Related]
20. Direct hemoperfusion with polymyxin B-immobilized cartridge in severe sepsis due to intestinal perforation: hemodynamic findings and clinical considerations in anticoagulation therapy.
Maynar J; Martínez-Sagasti F; Herrera-Gutiérrez M; Martí F; Candel FJ; Belda J; Castaño S; Sanchez-Izquierdo JÁ
Rev Esp Quimioter; 2013 Jun; 26(2):151-8. PubMed ID: 23817653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
